Bortether (1, 2 mg & 3.5 mgl.)

THERDOSE PHARMA PRIVATE LIMITED (INDIA)

“Bortether” contains Drug / Molecule called “Bortezomib”. Bortezomib is a reversible inhibitor of the chymotrypsin-like activity of proteasome. It prevents targeted proteolysis that affects multiple signaling cascades responsible for normal homeostatic functions within the cell, leading to cell death.

Indication

Bortether is used for the treatment of Multiple Myeloma. Also used for Mantle Cell Lymphoma.

Note

Precaution

  • Bortether is a prescription drug and should be used under proper medical guidance and advice.
  • Contraindicated  in patients with hypersensitivity to Bortezomib, boron or  mannitol.